Neurana Pharmaceuticals

United States
Wonewoc, Wisconsin, United States, 92122

Company profile

Neurana Pharmaceuticals company profile

Neurana Pharmaceuticals is a biotechnology company that is currently developing a novel treatment for acute muscle spasms. The company was founded in 2013 and headquartered in California, United States.

Business identity

Contact email
[email protected]
Phone number
+1 858-732-0700
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
92122
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$60M
Last funding
Series A / $60M / 2018-05-08
Last equity funding
Series A / $60M
Investors
5
Lead investors
1
Founders
2
Articles
10

Founders and investors

Founders

David HaleJudy Caron

Lead investors

Sofinnova Investments

Investors

H.I.G. BioHealth PartnersLongitude CapitalMagnaSci VenturesNew Leaf Venture PartnersSofinnova Investments